Johnson & Johnson to acquire Shockwave Medical for $13.1B

Johnson & Johnson announced a definitive agreement to acquire Shockwave Medical for $335.00 per share in cash, representing an enterprise value of approximately $13.1 billion. The acquisition expands Johnson & Johnson MedTech's cardiovascular portfolio.

“Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash.”jnj.com

• 1 source
• jnj.comJohnson & Johnson to Acquire Shockwave MedicalApr 5, 2024

Summarized from public sources; check the original articles before acting on it.